Latest Breaking News On - Analyst recommendations for west pharmaceutical services - Page 1 : comparemela.com

Analysts Set West Pharmaceutical Services, Inc (NYSE:WST) Target Price at $435 20

Analysts Set West Pharmaceutical Services, Inc (NYSE:WST) Target Price at $435 20
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Asia pacificCharles witherspoonJefferies financial groupNews ratings for west pharmaceutical services dailyServices dividend announcementServices stockInstitutional trading of west pharmaceutical servicesRaymond james associatesServices incServices company profileXponance incAnalyst recommendations for west pharmaceutical servicesRaymond james financial services advisors incCommonwealth equity servicesWest pharmaceutical servicesGet free report

UBS Group Trims West Pharmaceutical Services (NYSE:WST) Target Price to $375 00

UBS Group Trims West Pharmaceutical Services (NYSE:WST) Target Price to $375 00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Asia pacificJefferies financial groupFranklin resources incServices price performanceVanguard group incGeode capital managementT rowe price investment management incNews ratings for west pharmaceutical services dailyServices incServices announces dividendInsider transactions at west pharmaceutical servicesAnalyst recommendations for west pharmaceutical servicesArtisan partners limited partnershipWest pharmaceutical servicesFree reportModerate buy

UBS Group Lowers West Pharmaceutical Services (NYSE:WST) Price Target to $375 00

UBS Group Lowers West Pharmaceutical Services (NYSE:WST) Price Target to $375 00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesAsia pacificNews ratings for west pharmaceutical services dailyServices stock performanceJefferies financial groupServices incServices company profileServices dividend announcementSecurities exchange commissionAnalyst recommendations for west pharmaceutical servicesFaithward advisorsMercer global advisors incWest pharmaceutical servicesFree reportModerate buyPharmaceutical services

West Pharmaceutical Services (NYSE:WST) Rating Lowered to Hold at StockNews com

StockNews.com lowered shares of West Pharmaceutical Services (NYSE:WST – Free Report) from a buy rating to a hold rating in a research note published on Friday morning. Several other research analysts have also weighed in on WST. UBS Group dropped their price objective on shares of West Pharmaceutical Services from $400.00 to $375.00 and set […]

Asia pacificInternational assets investment managementServices announces dividendAddison advisorsJefferies financial groupSolutions incAnalyst recommendations for west pharmaceutical servicesServices stockSunbelt securities incInstitutional trading of west pharmaceutical servicesServices incNews ratings for west pharmaceutical services dailyWest pharmaceutical servicesFree reportModerate buyPharmaceutical services

West Pharmaceutical Services (NYSE:WST) Downgraded by StockNews com to Hold

West Pharmaceutical Services (NYSE:WST – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a note issued to investors on Friday. WST has been the subject of several other reports. Stephens lowered their target price on West Pharmaceutical Services from $420.00 to $390.00 and set an […]

Asia pacificInternational assets investment managementServices stockJefferies financial groupServices incFirst horizon advisors incSunbelt securities incSolutions incAnalyst recommendations for west pharmaceutical servicesNews ratings for west pharmaceutical services dailySecurities exchange commissionWest pharmaceutical servicesGet free reportPharmaceutical servicesExchange commissionHorizon advisors